Virtu Financial LLC Acquires Shares of 121,984 Teladoc Health, Inc. $TDOC

Virtu Financial LLC bought a new position in shares of Teladoc Health, Inc. (NYSE:TDOC) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 121,984 shares of the health services provider’s stock, valued at approximately $854,000. Virtu Financial LLC owned approximately 0.07% of Teladoc Health at the end of the most recent quarter.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Corient Private Wealth LLC boosted its stake in shares of Teladoc Health by 236.6% during the 4th quarter. Corient Private Wealth LLC now owns 37,692 shares of the health services provider’s stock valued at $264,000 after buying an additional 26,494 shares during the last quarter. Mackenzie Financial Corp increased its stake in shares of Teladoc Health by 38.6% in the fourth quarter. Mackenzie Financial Corp now owns 165,550 shares of the health services provider’s stock worth $1,157,000 after buying an additional 46,090 shares during the last quarter. Empowered Funds LLC increased its stake in shares of Teladoc Health by 1.9% in the fourth quarter. Empowered Funds LLC now owns 742,305 shares of the health services provider’s stock worth $5,196,000 after buying an additional 14,029 shares during the last quarter. Voloridge Investment Management LLC raised its holdings in Teladoc Health by 42.8% in the fourth quarter. Voloridge Investment Management LLC now owns 997,427 shares of the health services provider’s stock valued at $6,982,000 after acquiring an additional 299,086 shares in the last quarter. Finally, Polymer Capital Management US LLC raised its holdings in Teladoc Health by 32.0% in the fourth quarter. Polymer Capital Management US LLC now owns 22,443 shares of the health services provider’s stock valued at $157,000 after acquiring an additional 5,443 shares in the last quarter. 76.82% of the stock is currently owned by hedge funds and other institutional investors.

Teladoc Health Price Performance

Shares of NYSE TDOC opened at $8.06 on Monday. The stock has a market cap of $1.46 billion, a P/E ratio of -8.31 and a beta of 2.14. The firm’s 50-day simple moving average is $6.63 and its 200 day simple moving average is $6.23. Teladoc Health, Inc. has a fifty-two week low of $4.40 and a fifty-two week high of $9.77. The company has a quick ratio of 2.72, a current ratio of 2.80 and a debt-to-equity ratio of 0.75.

Teladoc Health (NYSE:TDOC) last released its quarterly earnings results on Wednesday, April 29th. The health services provider reported ($0.36) EPS for the quarter, missing analysts’ consensus estimates of ($0.35) by ($0.01). The company had revenue of $613.85 million for the quarter, compared to the consensus estimate of $611.04 million. Teladoc Health had a negative return on equity of 11.45% and a negative net margin of 6.81%.The firm’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same quarter last year, the firm posted ($0.53) earnings per share. Teladoc Health has set its FY 2026 guidance at -1.050–0.750 EPS and its Q2 2026 guidance at -0.300–0.200 EPS. Equities analysts expect that Teladoc Health, Inc. will post -0.92 EPS for the current year.

Insider Buying and Selling at Teladoc Health

In other news, CEO Charles Divita III sold 19,132 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total transaction of $145,977.16. Following the completion of the sale, the chief executive officer directly owned 389,894 shares of the company’s stock, valued at $2,974,891.22. This trade represents a 4.68% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of Teladoc Health stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $7.63, for a total value of $47,275.48. Following the completion of the transaction, the insider directly owned 57,671 shares in the company, valued at $440,029.73. This represents a 9.70% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last three months, insiders have sold 39,870 shares of company stock valued at $302,507. 0.70% of the stock is currently owned by corporate insiders.

Analysts Set New Price Targets

Several equities analysts have recently commented on TDOC shares. Citigroup increased their price target on shares of Teladoc Health from $6.00 to $7.00 and gave the stock a “neutral” rating in a research report on Tuesday, May 5th. TD Cowen lowered their price objective on Teladoc Health from $8.00 to $6.00 and set a “hold” rating for the company in a report on Thursday, February 26th. Canaccord Genuity Group cut their price objective on Teladoc Health from $12.00 to $10.00 and set a “buy” rating on the stock in a research note on Thursday, February 26th. Stifel Nicolaus reduced their target price on Teladoc Health from $8.00 to $6.00 and set a “hold” rating on the stock in a report on Thursday, February 26th. Finally, Barclays decreased their target price on Teladoc Health from $8.50 to $7.00 and set an “equal weight” rating for the company in a research report on Thursday, March 26th. Five equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Teladoc Health has an average rating of “Hold” and an average target price of $7.43.

Teladoc Health Profile

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.